# Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

NDC: 64850-511
Generic name: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Labeler / Manufacturer: Elite Laboratories, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20191216

FDA application: ANDA212037

## Active ingredients

- AMPHETAMINE ASPARTATE MONOHYDRATE: 2.5 mg/1
- AMPHETAMINE SULFATE: 2.5 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 2.5 mg/1
- DEXTROAMPHETAMINE SULFATE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64850-511"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64850-511
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=084c625c-94c6-4c8a-ba5f-6e26206dd903